STUDY OF EFFECT IN RESIDUAL GASTRIC VOLUME WITH TWO DIFFERENT DOSES OF DEXLANSOPRAZOLE IN DIABETIC PATIENTS POSTED FOR ELECTIVE SURGERIES

EFFICACY AND SAFETY OF TWO DIFFERENT DOSES OF DEXLANSOPRAZOLE IN ASSESSING FASTING GASTRIC RESIDUAL VOLUME BY USING ULTRASANOGRPHY IN DIABETIC PATIENTS UNDERGOING ELECTIVE SURGERY - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062392

Enrollment

184

Registered

2024-02-07

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: ASSESSMENT THE EFFICACY OF TWO DIFFERENT DOSES OF DEXLANSOPRAZOLE 30 Mg & 60 Mg: MEASUREMENT OF FASTING GASTRIC RESIDUAL VOLUME BY USING OF ULTRASONOGRAPHY, 2 HOURS PRIOR TO SURGERY Con

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS AGE BETWEEN 18 - 80 YEARS DIABETIC PATIENTS ADMITTED FOR ELECTIVE SURGERY WITH ASA GRADE 2 & 3

Exclusion criteria

Exclusion criteria: PATIENT HISTORY OF GASTRIC SURGERIES PREGNANT WOMEN PATIENT UNABLE TO TO POSITION IN RIGHT LATERAL DECUBITUS HISTORY OF ALLERGY TO DRUGS

Design outcomes

Primary

Measure	Time frame
MEASUREMENT OF FASTING GASTRIC RESIDUAL VOLUME IN TWO DIFFERENT DOSES OF DEXLANSOPRAZOLE 30 Mg & 60MgTimepoint: 2 hours prior to surgery	—

Secondary

Measure	Time frame
TO ASSESS THE POST OPERATIVE NAUSEA AND VOMITING WITHIN 24 HOURS.Timepoint: 24 HOURS	—

Countries

India

Contacts

Public ContactDR SRIDEVI MULIMANI

SHRI B.M PATIL MEDICAL COLLEGE ,BLDE (DEEMED TO BE UNIVERSITY )VIJAYAPURA

sridevi.mulimani@bldedu.ac.in9449534216

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026